Leukemia News and Features
A subset of antiviral immune cells could prevent CMV infections in bone marrow transplant recipients
A small subset of antiviral immune cells may be enough to fight and even prevent the disease caused by cytomegalovirus (CMV) in patients that receive bone marrow transplants.
Young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
The ASCO has announced that the transformation of treatment for chronic lymphocytic leukemia (CLL) is its Cancer Advance of the Year.
A new test may reveal which patients will respond to treatment for graft-versus-host disease (GVHD), a serious complication that can arise from stem cell SCT.
According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.
Leukemia Clinical Trials
- Drug combination suppresses growth of late-stage prostate cancer tumors
- Two genes that trigger most severe form of ovarian cancer are pinpointed
- Ultrasound helps determine which breast cancer patients need lymph nodes removed
- California breast density law slow to have an impact
- Epigenetic signatures differentiate triple negative breast cancers
- What determines cost-effectiveness of targeted anticancer therapies?
- Physician-controlled decisions in cancer care linked to lower quality rating
- Transfusion Indications for Patients With Cancer
- Lung cancer may be treatable with use of SapC-DOPS technology
- What autism can teach us about brain cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|